Late-Phase Vaccine Clinical Trials

New Zealand has the third-highest adult obesity rate in the OECD, making it a strong location for clinical trials in healthy weight management.

Proven metabolic clinical trials capability

Optimal Clinical Trials is a leading New Zealand patient recruitment site for late-phase metabolic clinical trials.

In a 2022 obesity (weight-loss) trial, Optimal Clinical Trials was the fastest and highest-performing global recruiter, achieving a 90% retention rate. The study was complex, with multiple infusions and additional subcutaneous injections, as well as regular DEXA scans, and dietary counselling that required tight planning and precision. Clear communication and strong support from the medical and research team kept participants engaged and visits on schedule.

Following the top recruitment result achieved and significant input into the trial data, Optimal Clinical Trials’ Senior Medical Advisor co-presented the study design with the trial’s sponsor at the American Diabetes Association (ADA) 2025 conference.

Learn more at https://www.optimalclinicaltrials.com/client-hub/pharmaceutical-biotech-and-cros